"This is the tip of the iceberg of what TIL can bring to the future of medicine," Patrick Hwu, CEO of Moffitt Cancer Center, told Axios.
TIL therapy works by extracting patients' T-cells directly from tumors and essentially "giving them the Club Med treatment," said Jason Bock, CEO of the Cell Therapy Manufacturing Center.
[
add
]
[
|
|
...
]